The binding of L-[3H]nicotine to a single class of high affinity sites in rat brain membranes

PM Lippiello and KG Fernandes

The binding of optically pure L-[3H]nicotine to rat brain membrane preparations was studied using a rapid filtration method. The binding properties observed depended on the method used for tissue isolation. The most consistent results were obtained with membranes prepared in the presence of protease inhibitors, without divalent cations. Binding was saturable, reversible, and stereospecific. Scatchard analysis revealed a single class of high affinity sites with an average KD of 2 nM and a Bmax of approximately 200 fmol/mg of protein. The Hill coefficient was near unity. The KD calculated from the kinetic rate constants for association (k1 = 0.012 min-1 nM-1) and dissociation (k-1 = 0.04 min-1) was around 3 nM, in good agreement with the dissociation constant determined from equilibrium binding. In competition studies, cholinergic agonists were generally the most effective in inhibiting L- [3H]nicotine binding, whereas antagonists were relatively ineffective. The D-isomer of nicotine was about 60-fold less potent than the L- isomer in inhibiting binding. The results were unaffected by temperature, with the exception that Bmax was somewhat lower at 37 degrees. The equilibrium binding properties of these sites were essentially identical in adult male and female brain. However, Bmax was lower in fetal brain tissue. The present findings are consistent with the idea that there is a single class of high affinity nicotinic binding sites in rat brain with cholinoceptive properties.

Volume 29, Issue 5, pp. 448-454, 05/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				E. Sántha, B. Sperlágh, T. Zelles, G. Zsilla, P. T. Tóth, B. Lendvai, M. Baranyi, and E. S. Vizi Multiple Cellular Mechanisms Mediate the Effect of Lobeline on the Release of Norepinephrine J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 302 - 307. [Abstract] [Full Text]

				A. G. Mukhin, D. Gündisch, A. G. Horti, A. O. Koren, G. Tamagnan, A. S. Kimes, J. Chambers, D. B. Vaupel, S. L. King, M. R. Picciotto, et al. 5-Iodo-A-85380, an alpha 4beta 2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors Mol. Pharmacol., March 1, 2000; 57(3): 642 - 649. [Abstract] [Full Text]

				M. I. Damaj, G. S. Patrick, K. R. Creasy, and B. R. Martin Pharmacology of Lobeline, A Nicotinic Receptor Ligand J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 410 - 419. [Abstract] [Full Text]

				L. Teng, P. A. Crooks, P. K. Sonsalla, and L. P. Dwoskin Lobeline and Nicotine Evoke [3H]Overflow from Rat Striatal Slices Preloaded with [3H]Dopamine: Differential Inhibition of Synaptosomal and Vesicular [3H]Dopamine Uptake J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1432 - 1444. [Abstract] [Full Text]